Skip to main content
. Author manuscript; available in PMC: 2010 Dec 9.
Published in final edited form as: Immunol Lett. 2008 Dec 25;122(1):68–75. doi: 10.1016/j.imlet.2008.12.002

Fig. 2.

Fig. 2

Schemes of the immunization protocols. The axis indicates 14 days intervals. Gene gun (a) and intradermal immunization protocol (b) using the constructs pCMV-F1, pCMV-F1/Tet, PCMV-mock and pCMV-P5. Subcutaneous application protocol (c) using rPhl p 5 as the immunization substance.